ID   PLPL8_RAT               Reviewed;         776 AA.
AC   D3ZRC4;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   02-OCT-2024, entry version 101.
DE   RecName: Full=Calcium-independent phospholipase A2-gamma {ECO:0000305};
DE            EC=3.1.1.- {ECO:0000250|UniProtKB:Q9NP80};
DE            EC=3.1.1.5 {ECO:0000250|UniProtKB:Q9NP80};
DE   AltName: Full=Intracellular membrane-associated calcium-independent phospholipase A2 gamma;
DE            Short=iPLA2-gamma;
DE   AltName: Full=Patatin-like phospholipase domain-containing protein 8;
GN   Name=Pnpla8 {ECO:0000312|RGD:1311444};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Li P.W., Adams M.D., Amanatides P.G., Baden-Tillson H.,
RA   Barnstead M., Chin S.H., Dew I., Evans C.A., Ferriera S., Flanigan M.,
RA   Fosler C., Glodek A., Gu Z., Holt R.A., Jennings D., Kraft C.L., Lu F.,
RA   Nguyen T., Nusskern D.R., Pfannkoch C.M., Sitter C., Sutton G.G.,
RA   Venter J.C., Wang Z., Woodage T., Zheng X.H., Zhong F.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15908428; DOI=10.1074/jbc.m502358200;
RA   Yan W., Jenkins C.M., Han X., Mancuso D.J., Sims H.F., Yang K., Gross R.W.;
RT   "The highly selective production of 2-arachidonoyl lysophosphatidylcholine
RT   catalyzed by purified calcium-independent phospholipase A2gamma:
RT   identification of a novel enzymatic mediator for the generation of a key
RT   branch point intermediate in eicosanoid signaling.";
RL   J. Biol. Chem. 280:26669-26679(2005).
CC   -!- FUNCTION: Calcium-independent and membrane-bound phospholipase, that
CC       catalyzes the esterolytic cleavage of fatty acids from
CC       glycerophospholipids to yield free fatty acids and lysophospholipids,
CC       hence regulating membrane physical properties and the release of lipid
CC       second messengers and growth factors. Hydrolyzes
CC       phosphatidylethanolamine, phosphatidylcholine and probably
CC       phosphatidylinositol with a possible preference for the former. Has
CC       also a broad substrate specificity in terms of fatty acid moieties,
CC       hydrolyzing saturated and mono-unsaturated fatty acids at nearly equal
CC       rates from either the sn-1 or sn-2 position in diacyl
CC       phosphatidylcholine. However, has a weak activity toward
CC       polyunsaturated fatty acids at the sn-2 position, and thereby favors
CC       the production of 2-arachidonoyl lysophosphatidylcholine, a key branch
CC       point metabolite in eicosanoid signaling. On the other hand, can
CC       produce arachidonic acid from the sn-1 position of diacyl phospholipid
CC       and from the sn-2 position of arachidonate-containing plasmalogen
CC       substrates. Therefore, plays an important role in the mobilization of
CC       arachidonic acid in response to cellular stimuli and the generation of
CC       lipid second messengers. Can also hydrolyze lysophosphatidylcholine. In
CC       the mitochondrial compartment, catalyzes the hydrolysis and release of
CC       oxidized aliphatic chains from cardiolipin and integrates mitochondrial
CC       bioenergetics and signaling. It is essential for maintaining efficient
CC       bioenergetic mitochondrial function through tailoring mitochondrial
CC       membrane lipid metabolism and composition.
CC       {ECO:0000250|UniProtKB:Q8K1N1, ECO:0000250|UniProtKB:Q9NP80}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15802;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 2-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:18689,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:57875;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18690;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + H2O = a 1-
CC         acyl-sn-glycero-3-phosphoethanolamine + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:44604, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:64381, ChEBI:CHEBI:64612;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44605;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         O-(1Z-alkenyl)-sn-glycero-3-phosphocholine + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:44068, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:77286, ChEBI:CHEBI:77287;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44069;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + H2O = a fatty acid +
CC         H(+) + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:15177,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16870,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:58168; EC=3.1.1.5;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15178;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(9Z,12Z)-octadecadienoyl-sn-glycero-3-phosphocholine
CC         + H2O = (9Z,12Z)-octadecadienoate + a 1-acyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:40643, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30245, ChEBI:CHEBI:58168,
CC         ChEBI:CHEBI:60000; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40644;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-
CC         phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + a 1-acyl-
CC         sn-glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:40651,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:58168, ChEBI:CHEBI:75063;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40652;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:40427, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:72998, ChEBI:CHEBI:73003;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40428;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-octadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:40819, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:73858,
CC         ChEBI:CHEBI:75034; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40820;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:38779, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73001; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38780;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphocholine + H2O = (9Z,12Z)-octadecadienoate + 1-hexadecanoyl-sn-
CC         glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:40811,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30245,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:73002;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40812;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(9Z,12Z)-octadecadienoyl-sn-glycero-3-
CC         phosphoethanolamine + H2O = (9Z,12Z)-octadecadienoate + a 1-acyl-sn-
CC         glycero-3-phosphoethanolamine + H(+); Xref=Rhea:RHEA:40639,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30245,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:75069;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40640;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-
CC         phosphoethanolamine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + a 1-
CC         acyl-sn-glycero-3-phosphoethanolamine + H(+); Xref=Rhea:RHEA:40647,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:75067;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40648;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphoethanolamine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40431, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73004, ChEBI:CHEBI:73009;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40432;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + H2O = 2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:40571, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:73003, ChEBI:CHEBI:76079;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40572;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = 2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H(+) +
CC         octadecanoate; Xref=Rhea:RHEA:40823, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25629, ChEBI:CHEBI:75034,
CC         ChEBI:CHEBI:76071; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40824;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-
CC         glycero-3-phosphocholine + H2O = 2-(4Z,7Z,10Z,13Z,16Z,19Z-
CC         docosahexaenoyl)-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41063, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:74963, ChEBI:CHEBI:76085;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41064;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(1Z)-hexadecenyl-2 (5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate +
CC         1-(1Z-hexadecenyl)-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:40579, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73850, ChEBI:CHEBI:77292;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40580;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(1Z-hexadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphocholine + H2O = (9Z)-octadecenoate + 1-(1Z-hexadecenyl)-sn-
CC         glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:67156,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:73850, ChEBI:CHEBI:86232;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67157;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:40435,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16870, ChEBI:CHEBI:72998;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40436;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1',3'-bis-[1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phospho]-glycerol + H2O = (9Z,12Z)-octadecadienoate + 1'-[1,2-di-
CC         (9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho]-3'-[1-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phospho]-glycerol + H(+);
CC         Xref=Rhea:RHEA:52812, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:83580, ChEBI:CHEBI:83581;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52813;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1'-[1-acyl-2-(9-hydroxy-(10E,12Z)-octadecadienoyl)-sn-glycero-
CC         3-phospho]-3'-[1,2-diacyl-sn-glycero-3-phospho]-glycerol + H2O = 1'-
CC         [1,2-diacyl-sn-glycero-3-phospho],3'-[1-acyl-sn-glycero-3-phospho]-
CC         glycerol + 9-hydroxy-(10E,12Z)-octadecadienoate + H(+);
CC         Xref=Rhea:RHEA:67272, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:64743, ChEBI:CHEBI:133820, ChEBI:CHEBI:167908;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67273;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- ACTIVITY REGULATION: Calcium-independent phospholipase.
CC       {ECO:0000250|UniProtKB:Q9NP80}.
CC   -!- PATHWAY: Phospholipid metabolism. {ECO:0000250|UniProtKB:Q9NP80}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q5XTS1}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NP80}. Microsome membrane
CC       {ECO:0000250|UniProtKB:Q5XTS1}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NP80}. Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:Q9NP80}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NP80}. Peroxisome membrane
CC       {ECO:0000305|PubMed:15908428}; Single-pass membrane protein
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC133400; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473947; EDM03350.1; -; Genomic_DNA.
DR   RefSeq; XP_003750198.1; XM_003750150.4.
DR   RefSeq; XP_003754218.1; XM_003754170.4.
DR   AlphaFoldDB; D3ZRC4; -.
DR   SMR; D3ZRC4; -.
DR   IntAct; D3ZRC4; 1.
DR   STRING; 10116.ENSRNOP00000049214; -.
DR   iPTMnet; D3ZRC4; -.
DR   PhosphoSitePlus; D3ZRC4; -.
DR   jPOST; D3ZRC4; -.
DR   PaxDb; 10116-ENSRNOP00000049214; -.
DR   PeptideAtlas; D3ZRC4; -.
DR   Ensembl; ENSRNOT00000047296.7; ENSRNOP00000049214.3; ENSRNOG00000039091.6.
DR   Ensembl; ENSRNOT00065015254; ENSRNOP00065011453; ENSRNOG00065009530.
DR   AGR; RGD:1311444; -.
DR   RGD; 1311444; Pnpla8.
DR   eggNOG; KOG4231; Eukaryota.
DR   GeneTree; ENSGT00940000154738; -.
DR   HOGENOM; CLU_000288_144_7_1; -.
DR   InParanoid; D3ZRC4; -.
DR   OMA; PEHYWRI; -.
DR   OrthoDB; 5477952at2759; -.
DR   PhylomeDB; D3ZRC4; -.
DR   TreeFam; TF319230; -.
DR   Reactome; R-RNO-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-RNO-1482839; Acyl chain remodelling of PE.
DR   PRO; PR:D3ZRC4; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Proteomes; UP000234681; Chromosome 6.
DR   Bgee; ENSRNOG00000039091; Expressed in quadriceps femoris and 19 other cell types or tissues.
DR   ExpressionAtlas; D3ZRC4; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; ISO:RGD.
DR   GO; GO:0005777; C:peroxisome; ISS:UniProtKB.
DR   GO; GO:0047499; F:calcium-independent phospholipase A2 activity; ISS:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008970; F:phospholipase A1 activity; IEA:RHEA.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0050482; P:arachidonic acid secretion; ISO:RGD.
DR   GO; GO:0032048; P:cardiolipin metabolic process; ISS:UniProtKB.
DR   GO; GO:0006631; P:fatty acid metabolic process; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0043651; P:linoleic acid metabolic process; ISO:RGD.
DR   GO; GO:0055088; P:lipid homeostasis; ISS:UniProtKB.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; ISO:RGD.
DR   GO; GO:0046338; P:phosphatidylethanolamine catabolic process; ISO:RGD.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; ISO:RGD.
DR   GO; GO:1900407; P:regulation of cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0070328; P:triglyceride homeostasis; ISS:UniProtKB.
DR   CDD; cd07211; Pat_PNPLA8; 1.
DR   Gene3D; 3.40.1090.10; Cytosolic phospholipase A2 catalytic domain; 1.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR045217; PNPLA8-like.
DR   InterPro; IPR002641; PNPLA_dom.
DR   PANTHER; PTHR24185; CALCIUM-INDEPENDENT PHOSPHOLIPASE A2-GAMMA; 1.
DR   PANTHER; PTHR24185:SF1; CALCIUM-INDEPENDENT PHOSPHOLIPASE A2-GAMMA; 1.
DR   Pfam; PF01734; Patatin; 1.
DR   SUPFAM; SSF52151; FabD/lysophospholipase-like; 1.
DR   PROSITE; PS51635; PNPLA; 1.
PE   3: Inferred from homology;
KW   Endoplasmic reticulum; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Membrane; Microsome; Mitochondrion; Peroxisome; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..776
FT                   /note="Calcium-independent phospholipase A2-gamma"
FT                   /id="PRO_0000450242"
FT   TRANSMEM        469..489
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          439..634
FT                   /note="PNPLA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   REGION          226..274
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          306..331
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           443..448
FT                   /note="GXGXXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           475..479
FT                   /note="GXSXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           621..623
FT                   /note="DGA/G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   COMPBIAS        259..274
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        310..331
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        477
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   ACT_SITE        621
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOD_RES         730
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K1N1"
SQ   SEQUENCE   776 AA;  87961 MW;  96808D538E5B8B27 CRC64;
     MSINLTLDIY IYFLNNARSF CGKQRSKQLN FLCSKQYWRM NHVNVHREFH TSKKSCKWNR
     SEAHCSKHWH SSSNHGVHIG IVKLSTSAPK GLTKVSIHMS RIKSTLNSVS KAIFGSQNEM
     VSRLAQFKPS SRIFRKVSDR GWLKHKNVKQ AIESLKNYSD KSAEKNSFAE QKSYFADKEE
     GSDKHSLYHY AYRITTRFGE SFYFLANHIN SYFKNKEKMS QIKEDRQLQD KPCLEESKSI
     SPSPDILTDR PDSGPPLNVE DKLSSSTQLP EALPVSTKQS IANFLSRPTE GVQALVGGYI
     GGLVPKLKSD PKSQPEEEEE PSKTDEPICK DKKAEEKKRV LLQREKIIAR VSIDNRTRAL
     VQALRRTTDP KLCITRVEEL TFHLLEFPEG KGVAVKEKII PYLLRLRQIK DETLQAAVRE
     ILALIGYVDP VKGRGIRILA IDGGGTRGVV ALQTLRKLVE LTQKPIHQLF DYICGVSTGA
     ILAFMLGLFH MPLDECEELY RKLGSDVFTQ NVIVGTVKMS WSHAFYDSHT WEKILKDKVG
     SALMIETARD PLCPKVAAVS TIVNRGQTPK AFVFRNYGHF PGTNSHYLGG CQYKMWQAIR
     ASSAAPGYFA EYALGNDLHQ DGGLLLNNPS ALALHECKCI WPDTPLECIV SLGTGRYESD
     VRNTTTYTSL KTKLSNVISS ATDTEEVHIM LDGLLPADTY FRFNPVICEN IPLDESRNEK
     LDQLQLEGMK YLERNDEKMK KLAKILSREK TTLQKISDWI KLKSDMYEGL PFFSKL
//
